March 31, 2026 — Cybersecurity shares fell sharply on March 27 after reports surfaced that Anthropic is testing a new AI system with advanced cyber capabilities and possible security concerns. The way news of Anthropic’s model is spooking investors in cybersecurity firms and other industries shows the disruptive potential of AI and underscores why early movers like Core AI Holdings Inc.
March 31, 2026 — Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.
March 31, 2026 — Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.
March 31, 2026 — This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.
March 31, 2026 — Annovis Bio (NYSE: ANVS) announced the publication of an article in The Scientist detailing the discovery and development of its lead drug candidate buntanetap, as the company advances ongoing Phase 3 and extension studies in Alzheimer’s disease and Parkinson’s disease. The company said the article provides historical and scientific context for buntanetap’s progression, with current trials showing approximately 70% enrollment in early Alzheimer’s and 20% enrollment in Parkinson’s, underscoring its focus on advancing neurodegenerative therapies toward key clinical and regulatory milestones.
March 31, 2026 — In the life sciences industry, a robust pipeline is widely recognized as a critical driver of value creation and sustainability. The significance of the UK designation extends beyond a single program.
March 31, 2026 — This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.
March 31, 2026 — Tonix Pharmaceuticals (NASDAQ: TNXP) announced positive Phase 1 data for TNX-4800, a long-acting monoclonal antibody targeting Borrelia burgdorferi, demonstrating rapid absorption, sustained protective levels for at least four months and a favorable safety profile in healthy subjects. The company said the single-dose subcutaneous therapy could offer a preventative option for Lyme disease, with plans to initiate an adaptive Phase 2 field study in the first half of 2027, pending FDA clearance, to evaluate protection in individuals in endemic areas.
March 31, 2026 — Beeline Holdings (NASDAQ: BLNE) reported fourth-quarter 2025 net revenue of $2. 5 million, up 127% year over year, on origination volume of $84.
March 31, 2026 — Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte(TM) for cutaneous T-cell lymphoma with interim analysis expected in Q2 2026 and top-line results anticipated in the second half of the year. The company also noted regulatory momentum with orphan drug designation for dusquetide in Behçet’s Disease, ongoing development of SGX302 and SGX945 programs and a year-end cash position of approximately $7.
March 31, 2026 — Nutriband (NASDAQ: NTRB) announced it has selected a proposed worldwide brand name for its abuse-deterrent fentanyl transdermal system, with plans to submit the name and product labeling to the FDA and international regulators as well as file for trademark protection. The company said the product, developed using its AVERSA(TM) technology, could become the first abuse-deterrent fentanyl patch designed to reduce misuse and accidental exposure, targeting a potential peak annual U.
March 31, 2026 — This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.
March 31, 2026 — Lantern Pharma (NASDAQ: LTRN) reported fourth-quarter and full-year 2025 operational highlights led by continued progress in its LP-300 Phase 2 HARMONIC trial, completion of targeted enrollment in Japan, planned protocol discussions with the FDA in mid-May 2026 and advancement of LP-184, LP-284 and STAR-001 across multiple oncology indications. The company said its AI-driven portfolio now targets an estimated annual market opportunity of more than $15 billion, while its RADR(R) platform and newly introduced withZeta.
March 31, 2026 — Cardiovascular disease remains the leading cause of death in the United States, representing a significant and persistent healthcare burden that the company’s solutions are designed to address. Cardio Diagnostics has developed a proprietary platform that integrates epigenetic and genetic biomarkers with artificial intelligence to generate personalized cardiovascular insights from a simple blood sample.
March 30, 2026 — Federal prosecutors have charged four individuals accused of operating multiple illegal cannabis cultivation sites across the Las Vegas Valley, according to information obtained by the 8 News Now Investigators. These arrests highlight the lengths to which black market marijuana operators will go to sustain their operations and make it harder for licensed companies like Curaleaf Holdings Inc.
March 30, 2026 — Battalion Oil (NYSE American: BATL) announced it entered into a definitive agreement to raise approximately $15 million through a private placement priced at $5. 50 per share, including prefunded warrants, with a new institutional investor.
March 30, 2026 — SEGG Media (NASDAQ: SEGG, LTRYW) announced the appointments of Daniel Bailey as chief commercial officer and Jack Clarke as chief strategy officer following its Veloce acquisition, as the company advances a 90-day plan focused on integration, execution, and monetization. The new executives bring experience scaling Veloce Media Group and driving global partnerships and revenue growth, with SEGG Media targeting near-term expansion through its digital assets, including Sports.
March 30, 2026 — Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.
March 30, 2026 — Datavault AI (NASDAQ: DVLT) issued a corrected press release providing additional clarity on its Mandela Dollar (MUSD) initiative, a proposed USD-pegged stablecoin being developed with Mandela Dlamini & Manaway L. L.
March 30, 2026 — Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.